SEATTLE, WA–(Marketwired – May 11, 2017) – CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article and CEO video interview discussing United Cannabis Inc.’s (OTCQB: CNAB) Prana Bio Medicinals, the company’s award winning line of cannabis treatments, and how its unique approach to medical marijuana benefits its patients while positioning the company to further refine and develop proven medicinal products.

Bridging the Gap with Patients
United Cannabis has developed a complete line-up of cannabinoids that are licensed to regulated dispensaries. In addition, the company’s A.C.T. Now program helps patients mix and match cannabinoids for therapeutic purposes. These products and services are designed to help bridge the gap between providing legal access to cannabis and helping patients effectively treat serious medical conditions at a time when many physicians remain skeptical.

The company’s Prana Bio Medicinal cannabinoid products use a patent-pending infusion process utilizing select fatty acids, lipids, and specific combinations of cannabis-derived terpenes to increase bioavailability. The capsules are packaged in airtight blister packs for 10-30-60 day regimen and are formulated with full-spectrum (e.g. whole plant) cannabis derived terpenes with various percentages of CBD and THC.

When a patient signs up for the complementary A.C.T. Now service, which comes free with Prana Bio Medicinal purchases, they are assigned to a nurse that will assess his or her current medications and create a personalized program for them. The patients then rely on a robust HIPPA-compliant cloud-based software to record their health conditions, schedule follow-ups, and continue to fine-tune their programs with their assigned health professional.

Experienced Leadership
United Cannabis’ Chief Executive Officer, Earnest Blackmon, and Chief Technical Officer, Tony Verzura, have been involved with medical cannabis since it was permissible in California in 1999. In 2009, they turned their focus to Colorado when medical cannabis was legalized. The team has more than 30 years of combined experience in the industry, including engineered facilities, security, regulatory compliance, genetics, cultivation, manufacturing, extraction, branding, and retail operations.

Since 2009, the company has accumulated observational data from more than 15,000 medical marijuana patients that have successfully used its Prana Bio and A.C.T. Now programs. These efforts caught the attention of prominent members of the medical community, including Brent Reynolds, Ph.D. and Dr. Barry Bialek, who went on to join the company’s Medical Advisory Board to help further develop its programs.

This highly-qualified team is committed to advancing the use of cannabinoid-based medicine with a focus on the refinement of genetics for medical-grade strains of CBD-rich cannabis plants. The company is also dedicated to bringing best practices across all areas of the industry, including operation, planning, products, governance, and patient care.

Please follow the link to read the full article and see the CEO interview: http://www.cannabisfn.com/united-cannabis-bridging-gap-mmj-patient-care/

Learn how to become a CFN Media featured company, brand or entrepreneur: http://www.cannabisfn.com/become-featured-company/

Download the CFN Media iOS mobile app to access the world of cannabis from your smart phone: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8

Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com

About CFN Media
CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.

Disclaimer:
Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC, which owns CFN Media and CannabisFN.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.